dalteparin has been researched along with Sarcoidosis, Pulmonary in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marc, K | 1 |
| Bourkadi, JE | 1 |
| Benamor, J | 1 |
| Iraqi, G | 1 |
1 other study available for dalteparin and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
[Thoracic venous thrombosis in the course of sarcoidosis].
Topics: Anticoagulants; Enoxaparin; Glucocorticoids; Humans; Male; Middle Aged; Prednisone; Sarcoidosis, Pul | 2008 |